Polycyclic organic compounds, Experimental cancer drugs, matrixscientific.com, Three-membered rings, Antineoplastic and immunomodulating drugs, Six-membered rings, Antineoplastic drugs, Cyclic compounds
Zosuquidar Trihydrochloride (167465-36-3)
Zosuquidar (also LY-335979) is an experimental antineoplastic drug. In 2010, it was announced that a phase III trial for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome did not meet its primary endpoint and Eli Lilly discontinued its development. Zosquidir inhibits P-glycoproteins.
4-Aminoquinoline is a form of aminoquinoline with the amino group at the 4-position of the quinoline. A variety of derivatives of 4-aminoquinoline are antimalarial agents useful in treating erythrocytic plasmodial infections. Examples include amodiaquine, chloroquine, and hydroxychloroquine.
N-ETHYL-P-TOLUENESULFONAMIDE (8047-99-2, 80-39-7)
N-ethyl-4-toluenesulfonamide · N-ethyl-4-toluenesulfonamide, potassium salt · N-ethyl-4-toluenesulfonamide, lithium salt
Pyrazine is a heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine is a symmetrical molecule with point group D2h. Pyrazine is less basic than pyridine, pyridazine and pyrimidine.